LAG3 transcriptomic expression correlates with high levels of PD 1, PD L1, PD L2, and CTLA 4 checkpoints and with high tumor mut ational burden across cancers | Labcorp Oncology Skip to main contentScroll Back to Top
Our global life sciences company brings diagnostic testing & drug development together.
LAG3 transcriptomic expression correlates with high levels of PD 1, PD L1, PD L2, and CTLA 4 checkpoints and with high tumor mut ational burden across cancers
Poster
LAG3 transcriptomic expression correlates with high levels of PD 1, PD L1, PD L2, and CTLA 4 checkpoints and with high tumor mut ational burden across cancers